Skip to main content
Top
Published in: Archives of Virology 4/2016

01-04-2016 | Original Article

Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC

Authors: Nicole Seggewiß, Hedi Verena Kruse, Rebecca Weilandt, Erna Domsgen, Andreas Dotzauer, Dajana Paulmann

Published in: Archives of Virology | Issue 4/2016

Login to get access

Abstract

In the course of hepatitis A virus (HAV) infections, the seven nonstructural proteins and their intermediates are barely detectable. Therefore, little is known about their functions and mechanisms of action. Ectopic expression of the presumably membrane-associated proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC allowed the intracellular localization of these proteins and their possible function during the replication cycle of HAV to be investigated. In this study, we used rhesus monkey kidney cells, which are commonly used for cell culture experiments, and human liver cells, which are the natural target cells. We detected specific associations of these proteins with distinct membrane compartments and the cytoskeleton, different morphological alterations of the respective structures, and specific effects on cellular functions. Besides comparable findings in both cell lines used with regard to localization and effects of the proteins examined, we also found distinct differences. The data obtained identify so far undocumented interactions with and effects of the HAV proteins investigated on cellular components, which may reflect unknown aspects of the interaction of HAV with the host cell, for example the modification of the ERGIC (ER-Golgi intermediate compartment) structure, an interaction with lipid droplets and lysosomes, and inhibition of the classical secretory pathway.
Literature
2.
go back to reference Gust ID, Feinstone SM (1988) Hepatitis A. CRC Press, Boca Raton Gust ID, Feinstone SM (1988) Hepatitis A. CRC Press, Boca Raton
3.
go back to reference Dotzauer A, Gebhardt U, Bieback K et al (2000) Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol 74:10950–10957CrossRefPubMedPubMedCentral Dotzauer A, Gebhardt U, Bieback K et al (2000) Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol 74:10950–10957CrossRefPubMedPubMedCentral
4.
go back to reference Bergmann EM, Mosimann SC, Chernaia MM et al (1997) The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J Virol 71:2436–2448PubMedPubMedCentral Bergmann EM, Mosimann SC, Chernaia MM et al (1997) The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J Virol 71:2436–2448PubMedPubMedCentral
5.
go back to reference Graff J, Richards OC, Swiderek KM et al (1999) Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol 73:6015–6023PubMedPubMedCentral Graff J, Richards OC, Swiderek KM et al (1999) Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol 73:6015–6023PubMedPubMedCentral
6.
go back to reference Martin A, Bénichou D, Chao SF et al (1999) Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase. J Virol 73:6220–6227PubMedPubMedCentral Martin A, Bénichou D, Chao SF et al (1999) Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase. J Virol 73:6220–6227PubMedPubMedCentral
7.
go back to reference Martin A, Escriou N, Chao SF et al (1995) Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology 213:213–222. doi:10.1006/viro.1995.1561 CrossRefPubMed Martin A, Escriou N, Chao SF et al (1995) Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology 213:213–222. doi:10.​1006/​viro.​1995.​1561 CrossRefPubMed
8.
go back to reference Probst C, Jecht M, Gauss-Müller V (1998) Processing of proteinase precursors and their effect on hepatitis A virus particle formation. J Virol 72:8013–8020PubMedPubMedCentral Probst C, Jecht M, Gauss-Müller V (1998) Processing of proteinase precursors and their effect on hepatitis A virus particle formation. J Virol 72:8013–8020PubMedPubMedCentral
9.
go back to reference Schultheiss T, Kusov YY, Gauss-Müller V (1994) Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B. Virology 198:275–281CrossRefPubMed Schultheiss T, Kusov YY, Gauss-Müller V (1994) Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B. Virology 198:275–281CrossRefPubMed
10.
13.
go back to reference Emerson SU, Huang YK, Purcell RH (1993) 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475–480CrossRefPubMed Emerson SU, Huang YK, Purcell RH (1993) 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475–480CrossRefPubMed
14.
go back to reference Paulmann D, Magulski T, Schwarz R et al (2008) Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J Gen Virol 89:1593–1604. doi:10.1099/vir.0.83521-0 CrossRefPubMed Paulmann D, Magulski T, Schwarz R et al (2008) Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J Gen Virol 89:1593–1604. doi:10.​1099/​vir.​0.​83521-0 CrossRefPubMed
18.
go back to reference Kusov YY, Probst C, Jecht M et al (1998) Membrane association and RNA binding of recombinant hepatitis A virus protein 2C. Arch Virol 143:931–944CrossRefPubMed Kusov YY, Probst C, Jecht M et al (1998) Membrane association and RNA binding of recombinant hepatitis A virus protein 2C. Arch Virol 143:931–944CrossRefPubMed
20.
go back to reference Porter AG (1993) Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J Virol 67:6917–6921PubMedPubMedCentral Porter AG (1993) Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J Virol 67:6917–6921PubMedPubMedCentral
22.
go back to reference Cohen JI, Ticehurst JR, Purcell RH et al (1987) Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 61:50–59PubMedPubMedCentral Cohen JI, Ticehurst JR, Purcell RH et al (1987) Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 61:50–59PubMedPubMedCentral
25.
go back to reference Doedens JR, Kirkegaard K (1995) Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 14:894–907PubMedPubMedCentral Doedens JR, Kirkegaard K (1995) Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 14:894–907PubMedPubMedCentral
26.
go back to reference Beske O, Reichelt M, Taylor MP et al (2007) Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci 120:3207–3218. doi:10.1242/jcs.03483 CrossRefPubMed Beske O, Reichelt M, Taylor MP et al (2007) Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci 120:3207–3218. doi:10.​1242/​jcs.​03483 CrossRefPubMed
28.
go back to reference Barlowe C, Orci L, Yeung T et al (1994) COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77:895–907CrossRefPubMed Barlowe C, Orci L, Yeung T et al (1994) COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77:895–907CrossRefPubMed
29.
go back to reference Balch WE, McCaffery JM, Plutner H, Farquhar MG (1994) Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum. Cell 76:841–852CrossRefPubMed Balch WE, McCaffery JM, Plutner H, Farquhar MG (1994) Vesicular stomatitis virus glycoprotein is sorted and concentrated during export from the endoplasmic reticulum. Cell 76:841–852CrossRefPubMed
30.
go back to reference Bannykh SI, Rowe T, Balch WE (1996) The organization of endoplasmic reticulum export complexes. J Cell Biol 135:19–35CrossRefPubMed Bannykh SI, Rowe T, Balch WE (1996) The organization of endoplasmic reticulum export complexes. J Cell Biol 135:19–35CrossRefPubMed
31.
go back to reference Hirschberg K, Lippincott-Schwartz J (1999) Secretory pathway kinetics and in vivo analysis of protein traffic from the Golgi complex to the cell surface. FASEB J 13(Suppl 2):S251–S256PubMed Hirschberg K, Lippincott-Schwartz J (1999) Secretory pathway kinetics and in vivo analysis of protein traffic from the Golgi complex to the cell surface. FASEB J 13(Suppl 2):S251–S256PubMed
32.
go back to reference Dotzauer A, Feinstone SM, Kaplan G (1994) Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol 68:6064–6068PubMedPubMedCentral Dotzauer A, Feinstone SM, Kaplan G (1994) Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol 68:6064–6068PubMedPubMedCentral
33.
go back to reference Vallbracht A, Hofmann L, Wurster KG, Flehmig B (1984) Persistent infection of human fibroblasts by hepatitis A virus. J Gen Virol 65:609–615CrossRefPubMed Vallbracht A, Hofmann L, Wurster KG, Flehmig B (1984) Persistent infection of human fibroblasts by hepatitis A virus. J Gen Virol 65:609–615CrossRefPubMed
34.
go back to reference Gauss-Müller V, Deinhardt F (1984) Effect of hepatitis A virus infection on cell metabolism in vitro. Proc Soc Exp Biol Med 175:10–15CrossRefPubMed Gauss-Müller V, Deinhardt F (1984) Effect of hepatitis A virus infection on cell metabolism in vitro. Proc Soc Exp Biol Med 175:10–15CrossRefPubMed
35.
go back to reference Anderson DA (1987) Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175. J Med Virol 22:35–44CrossRefPubMed Anderson DA (1987) Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175. J Med Virol 22:35–44CrossRefPubMed
36.
go back to reference Rueckert RR (1990) Virology, 2nd edn. Raven Press, New York Rueckert RR (1990) Virology, 2nd edn. Raven Press, New York
37.
go back to reference Gauss-Müller V, Lottspeich F, Deinhardt F (1986) Characterization of hepatitis A virus structural proteins. Virology 155:732–736CrossRefPubMed Gauss-Müller V, Lottspeich F, Deinhardt F (1986) Characterization of hepatitis A virus structural proteins. Virology 155:732–736CrossRefPubMed
38.
go back to reference Updike WS, Tesar M, Ehrenfeld E (1991) Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology 185:411–418CrossRefPubMed Updike WS, Tesar M, Ehrenfeld E (1991) Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology 185:411–418CrossRefPubMed
39.
go back to reference Van Kuppeveld FJ, Galama JM, Zoll J, Van Den Hurk PJ (1996) Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication. J Virol 70:3876–3886 Van Kuppeveld FJ, Galama JM, Zoll J, Van Den Hurk PJ (1996) Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication. J Virol 70:3876–3886
40.
go back to reference Cheung W, Gill M, Esposito A et al (2010) Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84:6782–6798. doi:10.1128/JVI.01757-09 CrossRefPubMedPubMedCentral Cheung W, Gill M, Esposito A et al (2010) Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84:6782–6798. doi:10.​1128/​JVI.​01757-09 CrossRefPubMedPubMedCentral
44.
go back to reference Bienz K, Egger D, Pasamontes L (1987) Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160:220–226CrossRefPubMed Bienz K, Egger D, Pasamontes L (1987) Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160:220–226CrossRefPubMed
45.
go back to reference Suhy DA, Giddings TH, Kirkegaard K (2000) Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 74:8953–8965CrossRefPubMedPubMedCentral Suhy DA, Giddings TH, Kirkegaard K (2000) Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 74:8953–8965CrossRefPubMedPubMedCentral
46.
go back to reference Egger D, Teterina N, Ehrenfeld E, Bienz K (2000) Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol 74:6570–6580CrossRefPubMedPubMedCentral Egger D, Teterina N, Ehrenfeld E, Bienz K (2000) Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol 74:6570–6580CrossRefPubMedPubMedCentral
49.
go back to reference Dunn WA (1990) Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol 110:1923–1933CrossRefPubMed Dunn WA (1990) Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol 110:1923–1933CrossRefPubMed
50.
51.
52.
go back to reference Morace G, Kusov Y, Dzagurov G et al (2008) The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis. BMB Rep 41:678–683CrossRefPubMed Morace G, Kusov Y, Dzagurov G et al (2008) The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis. BMB Rep 41:678–683CrossRefPubMed
Metadata
Title
Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC
Authors
Nicole Seggewiß
Hedi Verena Kruse
Rebecca Weilandt
Erna Domsgen
Andreas Dotzauer
Dajana Paulmann
Publication date
01-04-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 4/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2723-5

Other articles of this Issue 4/2016

Archives of Virology 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.